Cosmo Pharmaceuticals NV (OTCPK:CMOPF)
$ 66.9252 0 (0%) Market Cap: 1.14 Bil Enterprise Value: 1.01 Bil PE Ratio: 15.34 PB Ratio: 2.13 GF Score: 84/100

Half Year 2023 Cosmo Pharmaceuticals NV Earnings Call Transcript

Jul 26, 2023 / 12:00PM GMT
Release Date Price: $50.3
Operator

Ladies and gentlemen, welcome to the Cosmo Pharmaceuticals release of Half Year Results 2023 Conference Call and live webcast. I am Alice, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to Alessandro Della Cha, Executive Director, CEO. Please go ahead, sir.

Alessandro E. Della Cha
Cosmo Pharmaceuticals N.V. - CEO & Executive Director

Good afternoon, everyone and welcome to our half year results report where we're giving you an update on our progress. I hope you can all see the presentation on your screen. Presentation is divided into 5 sections I think the title under one is gone, I don't know why but the title of the first section is the following: Investment strengths.

We believe that we are performing according to our plans and according to our expectation and hence, we would like to recap first and foremost before going into the details of the presentation or what

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot